Global Peramivir Market Research Report 2025(Status and Outlook)

August 2025 | 136 pages | ID: G02847F3684FEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Peramivir is a synthetic cyclopentane derivative. The groups connected to the ring include hydrophilic carboxyl and guanidine groups, as well as hydrophobic isopentyl and acetamido groups. The four groups with different polarities act on Different active site regions in the NA structure of influenza virus. This medicine is suitable for treating influenza A and is mainly administered intravenously in the form of sodium chloride solution.

This report offers a comprehensive and in-depth analysis of the global Peramivir market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Peramivir market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Peramivir market.

Global Peramivir Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co.Ltd.
SCOLR Pharma

Market Segmentation (by Type)

Solution
Solid

Market Segmentation (by Application)

Influenza A Treatment
Influenza B Treatment

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Peramivir Market
  • Overview of the regional outlook of the Peramivir Market:
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline


Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peramivir Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Peramivir, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Peramivir
1.2 Key Market Segments
  1.2.1 Peramivir Segment by Type
  1.2.2 Peramivir Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PERAMIVIR MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Peramivir Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Peramivir Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PERAMIVIR MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Peramivir Product Life Cycle
3.3 Global Peramivir Sales by Manufacturers (2020-2025)
3.4 Global Peramivir Revenue Market Share by Manufacturers (2020-2025)
3.5 Peramivir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peramivir Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Peramivir Market Competitive Situation and Trends
  3.8.1 Peramivir Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Peramivir Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PERAMIVIR INDUSTRY CHAIN ANALYSIS

4.1 Peramivir Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PERAMIVIR MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Peramivir Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Peramivir Market
5.7 ESG Ratings of Leading Companies

6 PERAMIVIR MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peramivir Sales Market Share by Type (2020-2025)
6.3 Global Peramivir Market Size Market Share by Type (2020-2025)
6.4 Global Peramivir Price by Type (2020-2025)

7 PERAMIVIR MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peramivir Market Sales by Application (2020-2025)
7.3 Global Peramivir Market Size (M USD) by Application (2020-2025)
7.4 Global Peramivir Sales Growth Rate by Application (2020-2025)

8 PERAMIVIR MARKET SALES BY REGION

8.1 Global Peramivir Sales by Region
  8.1.1 Global Peramivir Sales by Region
  8.1.2 Global Peramivir Sales Market Share by Region
8.2 Global Peramivir Market Size by Region
  8.2.1 Global Peramivir Market Size by Region
  8.2.2 Global Peramivir Market Size Market Share by Region
8.3 North America
  8.3.1 North America Peramivir Sales by Country
  8.3.2 North America Peramivir Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Peramivir Sales by Country
  8.4.2 Europe Peramivir Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Peramivir Sales by Region
  8.5.2 Asia Pacific Peramivir Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Peramivir Sales by Country
  8.6.2 South America Peramivir Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Peramivir Sales by Region
  8.7.2 Middle East and Africa Peramivir Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PERAMIVIR MARKET PRODUCTION BY REGION

9.1 Global Production of Peramivir by Region(2020-2025)
9.2 Global Peramivir Revenue Market Share by Region (2020-2025)
9.3 Global Peramivir Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Peramivir Production
  9.4.1 North America Peramivir Production Growth Rate (2020-2025)
  9.4.2 North America Peramivir Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Peramivir Production
  9.5.1 Europe Peramivir Production Growth Rate (2020-2025)
  9.5.2 Europe Peramivir Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Peramivir Production (2020-2025)
  9.6.1 Japan Peramivir Production Growth Rate (2020-2025)
  9.6.2 Japan Peramivir Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Peramivir Production (2020-2025)
  9.7.1 China Peramivir Production Growth Rate (2020-2025)
  9.7.2 China Peramivir Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 BioCryst Pharmaceuticals
  10.1.1 BioCryst Pharmaceuticals Basic Information
  10.1.2 BioCryst Pharmaceuticals Peramivir Product Overview
  10.1.3 BioCryst Pharmaceuticals Peramivir Product Market Performance
  10.1.4 BioCryst Pharmaceuticals Business Overview
  10.1.5 BioCryst Pharmaceuticals SWOT Analysis
  10.1.6 BioCryst Pharmaceuticals Recent Developments
10.2 Green Cross Pharma
  10.2.1 Green Cross Pharma Basic Information
  10.2.2 Green Cross Pharma Peramivir Product Overview
  10.2.3 Green Cross Pharma Peramivir Product Market Performance
  10.2.4 Green Cross Pharma Business Overview
  10.2.5 Green Cross Pharma SWOT Analysis
  10.2.6 Green Cross Pharma Recent Developments
10.3 Shionogi Co.
  10.3.1 Shionogi Co. Basic Information
  10.3.2 Shionogi Co. Peramivir Product Overview
  10.3.3 Shionogi Co. Peramivir Product Market Performance
  10.3.4 Shionogi Co. Business Overview
  10.3.5 Shionogi Co. SWOT Analysis
  10.3.6 Shionogi Co. Recent Developments
10.4 NeoPharm
  10.4.1 NeoPharm Basic Information
  10.4.2 NeoPharm Peramivir Product Overview
  10.4.3 NeoPharm Peramivir Product Market Performance
  10.4.4 NeoPharm Business Overview
  10.4.5 NeoPharm Recent Developments
10.5 Moksha8 Pharma
  10.5.1 Moksha8 Pharma Basic Information
  10.5.2 Moksha8 Pharma Peramivir Product Overview
  10.5.3 Moksha8 Pharma Peramivir Product Market Performance
  10.5.4 Moksha8 Pharma Business Overview
  10.5.5 Moksha8 Pharma Recent Developments
10.6 NT Pharma
  10.6.1 NT Pharma Basic Information
  10.6.2 NT Pharma Peramivir Product Overview
  10.6.3 NT Pharma Peramivir Product Market Performance
  10.6.4 NT Pharma Business Overview
  10.6.5 NT Pharma Recent Developments
10.7 Merck
  10.7.1 Merck Basic Information
  10.7.2 Merck Peramivir Product Overview
  10.7.3 Merck Peramivir Product Market Performance
  10.7.4 Merck Business Overview
  10.7.5 Merck Recent Developments
10.8 Hikma Pharmaceuticals
  10.8.1 Hikma Pharmaceuticals Basic Information
  10.8.2 Hikma Pharmaceuticals Peramivir Product Overview
  10.8.3 Hikma Pharmaceuticals Peramivir Product Market Performance
  10.8.4 Hikma Pharmaceuticals Business Overview
  10.8.5 Hikma Pharmaceuticals Recent Developments
10.9 Hunan Nucien Pharmaceutical Co.Ltd.
  10.9.1 Hunan Nucien Pharmaceutical Co.Ltd. Basic Information
  10.9.2 Hunan Nucien Pharmaceutical Co.Ltd. Peramivir Product Overview
  10.9.3 Hunan Nucien Pharmaceutical Co.Ltd. Peramivir Product Market Performance
  10.9.4 Hunan Nucien Pharmaceutical Co.Ltd. Business Overview
  10.9.5 Hunan Nucien Pharmaceutical Co.Ltd. Recent Developments
10.10 SCOLR Pharma
  10.10.1 SCOLR Pharma Basic Information
  10.10.2 SCOLR Pharma Peramivir Product Overview
  10.10.3 SCOLR Pharma Peramivir Product Market Performance
  10.10.4 SCOLR Pharma Business Overview
  10.10.5 SCOLR Pharma Recent Developments

11 PERAMIVIR MARKET FORECAST BY REGION

11.1 Global Peramivir Market Size Forecast
11.2 Global Peramivir Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Peramivir Market Size Forecast by Country
  11.2.3 Asia Pacific Peramivir Market Size Forecast by Region
  11.2.4 South America Peramivir Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Peramivir by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Peramivir Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Peramivir by Type (2026-2033)
  12.1.2 Global Peramivir Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Peramivir by Type (2026-2033)
12.2 Global Peramivir Market Forecast by Application (2026-2033)
  12.2.1 Global Peramivir Sales (K MT) Forecast by Application
  12.2.2 Global Peramivir Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peramivir Market Size Comparison by Region (M USD)
Table 5. Global Peramivir Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Peramivir Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Peramivir Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Peramivir Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peramivir as of 2024)
Table 10. Global Market Peramivir Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Peramivir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Peramivir Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Peramivir Sales by Type (K MT)
Table 26. Global Peramivir Market Size by Type (M USD)
Table 27. Global Peramivir Sales (K MT) by Type (2020-2025)
Table 28. Global Peramivir Sales Market Share by Type (2020-2025)
Table 29. Global Peramivir Market Size (M USD) by Type (2020-2025)
Table 30. Global Peramivir Market Size Share by Type (2020-2025)
Table 31. Global Peramivir Price (USD/KG) by Type (2020-2025)
Table 32. Global Peramivir Sales (K MT) by Application
Table 33. Global Peramivir Market Size by Application
Table 34. Global Peramivir Sales by Application (2020-2025) & (K MT)
Table 35. Global Peramivir Sales Market Share by Application (2020-2025)
Table 36. Global Peramivir Market Size by Application (2020-2025) & (M USD)
Table 37. Global Peramivir Market Share by Application (2020-2025)
Table 38. Global Peramivir Sales Growth Rate by Application (2020-2025)
Table 39. Global Peramivir Sales by Region (2020-2025) & (K MT)
Table 40. Global Peramivir Sales Market Share by Region (2020-2025)
Table 41. Global Peramivir Market Size by Region (2020-2025) & (M USD)
Table 42. Global Peramivir Market Size Market Share by Region (2020-2025)
Table 43. North America Peramivir Sales by Country (2020-2025) & (K MT)
Table 44. North America Peramivir Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Peramivir Sales by Country (2020-2025) & (K MT)
Table 46. Europe Peramivir Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Peramivir Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Peramivir Market Size by Region (2020-2025) & (M USD)
Table 49. South America Peramivir Sales by Country (2020-2025) & (K MT)
Table 50. South America Peramivir Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Peramivir Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Peramivir Market Size by Region (2020-2025) & (M USD)
Table 53. Global Peramivir Production (K MT) by Region(2020-2025)
Table 54. Global Peramivir Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Peramivir Revenue Market Share by Region (2020-2025)
Table 56. Global Peramivir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Peramivir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Peramivir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Peramivir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Peramivir Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. BioCryst Pharmaceuticals Basic Information
Table 62. BioCryst Pharmaceuticals Peramivir Product Overview
Table 63. BioCryst Pharmaceuticals Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. BioCryst Pharmaceuticals Business Overview
Table 65. BioCryst Pharmaceuticals SWOT Analysis
Table 66. BioCryst Pharmaceuticals Recent Developments
Table 67. Green Cross Pharma Basic Information
Table 68. Green Cross Pharma Peramivir Product Overview
Table 69. Green Cross Pharma Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Green Cross Pharma Business Overview
Table 71. Green Cross Pharma SWOT Analysis
Table 72. Green Cross Pharma Recent Developments
Table 73. Shionogi Co. Basic Information
Table 74. Shionogi Co. Peramivir Product Overview
Table 75. Shionogi Co. Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Shionogi Co. Business Overview
Table 77. Shionogi Co. SWOT Analysis
Table 78. Shionogi Co. Recent Developments
Table 79. NeoPharm Basic Information
Table 80. NeoPharm Peramivir Product Overview
Table 81. NeoPharm Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. NeoPharm Business Overview
Table 83. NeoPharm Recent Developments
Table 84. Moksha8 Pharma Basic Information
Table 85. Moksha8 Pharma Peramivir Product Overview
Table 86. Moksha8 Pharma Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Moksha8 Pharma Business Overview
Table 88. Moksha8 Pharma Recent Developments
Table 89. NT Pharma Basic Information
Table 90. NT Pharma Peramivir Product Overview
Table 91. NT Pharma Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. NT Pharma Business Overview
Table 93. NT Pharma Recent Developments
Table 94. Merck Basic Information
Table 95. Merck Peramivir Product Overview
Table 96. Merck Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Merck Business Overview
Table 98. Merck Recent Developments
Table 99. Hikma Pharmaceuticals Basic Information
Table 100. Hikma Pharmaceuticals Peramivir Product Overview
Table 101. Hikma Pharmaceuticals Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Hikma Pharmaceuticals Business Overview
Table 103. Hikma Pharmaceuticals Recent Developments
Table 104. Hunan Nucien Pharmaceutical Co.Ltd. Basic Information
Table 105. Hunan Nucien Pharmaceutical Co.Ltd. Peramivir Product Overview
Table 106. Hunan Nucien Pharmaceutical Co.Ltd. Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Hunan Nucien Pharmaceutical Co.Ltd. Business Overview
Table 108. Hunan Nucien Pharmaceutical Co.Ltd. Recent Developments
Table 109. SCOLR Pharma Basic Information
Table 110. SCOLR Pharma Peramivir Product Overview
Table 111. SCOLR Pharma Peramivir Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. SCOLR Pharma Business Overview
Table 113. SCOLR Pharma Recent Developments
Table 114. Global Peramivir Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Peramivir Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Peramivir Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Peramivir Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Peramivir Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Peramivir Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Peramivir Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Peramivir Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Peramivir Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Peramivir Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Peramivir Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Peramivir Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Peramivir Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Peramivir Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Peramivir Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Peramivir Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Peramivir Market Size Forecast by Application (2026-2033) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Peramivir
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peramivir Market Size (M USD), 2024-2033
Figure 5. Global Peramivir Market Size (M USD) (2020-2033)
Figure 6. Global Peramivir Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peramivir Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peramivir Product Life Cycle
Figure 13. Peramivir Sales Share by Manufacturers in 2024
Figure 14. Global Peramivir Revenue Share by Manufacturers in 2024
Figure 15. Peramivir Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Peramivir Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peramivir Revenue in 2024
Figure 18. Industry Chain Map of Peramivir
Figure 19. Global Peramivir Market PEST Analysis
Figure 20. Global Peramivir Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Peramivir Market Share by Type
Figure 27. Sales Market Share of Peramivir by Type (2020-2025)
Figure 28. Sales Market Share of Peramivir by Type in 2024
Figure 29. Market Size Share of Peramivir by Type (2020-2025)
Figure 30. Market Size Share of Peramivir by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Peramivir Market Share by Application
Figure 33. Global Peramivir Sales Market Share by Application (2020-2025)
Figure 34. Global Peramivir Sales Market Share by Application in 2024
Figure 35. Global Peramivir Market Share by Application (2020-2025)
Figure 36. Global Peramivir Market Share by Application in 2024
Figure 37. Global Peramivir Sales Growth Rate by Application (2020-2025)
Figure 38. Global Peramivir Sales Market Share by Region (2020-2025)
Figure 39. Global Peramivir Market Size Market Share by Region (2020-2025)
Figure 40. North America Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Peramivir Sales Market Share by Country in 2024
Figure 43. North America Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Peramivir Market Size Market Share by Country in 2024
Figure 45. U.S. Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Peramivir Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Peramivir Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Peramivir Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Peramivir Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Peramivir Sales Market Share by Country in 2024
Figure 53. Europe Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Peramivir Market Size Market Share by Country in 2024
Figure 55. Germany Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Peramivir Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Peramivir Sales Market Share by Region in 2024
Figure 67. Asia Pacific Peramivir Market Size Market Share by Region in 2024
Figure 68. China Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Peramivir Sales and Growth Rate (K MT)
Figure 79. South America Peramivir Sales Market Share by Country in 2024
Figure 80. South America Peramivir Market Size and Growth Rate (M USD)
Figure 81. South America Peramivir Market Size Market Share by Country in 2024
Figure 82. Brazil Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Peramivir Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Peramivir Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Peramivir Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Peramivir Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Peramivir Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Peramivir Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Peramivir Production Market Share by Region (2020-2025)
Figure 103. North America Peramivir Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Peramivir Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Peramivir Production (K MT) Growth Rate (2020-2025)
Figure 106. China Peramivir Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Peramivir Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Peramivir Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Peramivir Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Peramivir Market Share Forecast by Type (2026-2033)
Figure 111. Global Peramivir Sales Forecast by Application (2026-2033)
Figure 112. Global Peramivir Market Share Forecast by Application (2026-2033)


More Publications